logo

BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 27-12-2024
AUM:

₹ 341.35 Cr

Expense Ratio

2.37%

Benchmark

BSE Healthcare TRI

ISIN

INF0QA701995

Minimum Investment

500.0

Minimum Topup

100.0

Minimum SIP Amount

500

Fund Manager

FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)

Fund Performance 1Y (%) 3Y (%) 5Y (%)
BAJAJ FINSERV HEALTHCARE FUND - REGULAR - IDCW - - -
Benchmark - - -
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
9.757
Last change
0.01 (0.1127%)
Fund Size (AUM)
₹ 341.35 Cr
Performance
-3.19% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there is no assurance that the investment objective of the Scheme will be achieved.

Fund Manager
FM 1 - Mr. Nimesh Chandan (Equity Portion) , FM 2 - Mr. Sorbh Gupta (Equity Portion) , FM-3- Mr. Siddharth Chaudhary (Debt Portion)
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 7.94
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 7.48
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- 6.01
CIPLA LIMITED EQ NEW FV RS.2/- 5.32
BIOCON LIMITED EQ 3.76
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- 3.45
EMCURE PHARMACEUTICALS LIMITED EQ 3.39
Dr. Reddys Laboratories Ltd 3.37
SYNGENE INTERNATIONAL LIMITED EQ 3.25
FORTIS HEALTHCARE LIMITED. EQ 3.2

Sector Allocation

Sector Holdings (%)
Healthcare 84.14
Fast Moving Consumer Goods 7.53
Financial Services 2.09
Consumer Services 1.41
Capital Goods 1.15
Chemicals 0.43